These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7703816)

  • 1. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug screening in an Austrian prison].
    Lapornik R; Lehofer M; Rous F; Klampfer H; Hofmann P; Zapotoczky HG
    Nervenarzt; 1994 Sep; 65(9):633-4. PubMed ID: 7991011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Keystone Diagnostic Quik Test. A paper chromatography test for drugs of abuse in urine.
    Schwartz RH; Bogema S; Thorne MM
    Arch Pathol Lab Med; 1989 Apr; 113(4):363-4. PubMed ID: 2650652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 7. Preemployment drug screening. The epidemiologic issues.
    Zwerling C; Ryan J
    J Occup Med; 1992 Jun; 34(6):595-9. PubMed ID: 1619489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug screening in "normal" controls.
    Swerdlow NR; Geyer MA; Perry W; Cadenhead K; Braff DL
    Biol Psychiatry; 1995 Jul; 38(2):123-4. PubMed ID: 7578645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advantages and limitations of Triage DOA screening in clinical and forensic drug testing].
    Moriya F
    Chudoku Kenkyu; 2008 Jul; 21(3):273-83. PubMed ID: 18712071
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal toxicology screening.
    Hansen RL; Evans AT; Gillogley KM; Hughes CS; Krener PG
    J Perinatol; 1992 Sep; 12(3):220-4. PubMed ID: 1432276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary comparative study on the usefulness of instant-view'TM M-1 and Triage DOA in testing for drugs-of-abuse in forensic urine samples].
    Moriya F
    Chudoku Kenkyu; 2012 Sep; 25(3):243-6. PubMed ID: 23057404
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus.
    Chasnoff IJ; Wells AM; McGourty RF; Bailey LK
    J Perinatol; 2007 Dec; 27(12):744-8. PubMed ID: 17805340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine.
    Reidy L; Walls HC; Steele BW
    Ther Drug Monit; 2011 Jun; 33(3):366-8. PubMed ID: 21436763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Workplace testing of drugs of abuse and psychotropic drugs].
    Mura P; Saussereau E; Brunet B; Goullé JP
    Ann Pharm Fr; 2012 May; 70(3):120-32. PubMed ID: 22655580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of rapid tests in drug substitution].
    Scholer A
    Praxis (Bern 1994); 2002 Sep; 91(37):1465-6. PubMed ID: 12360681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.